Wearable Injectors and Connected Devices Conference 2021

Wearable Injectors and Connected Devices Conference is organized by SMi Group Ltd and will be held from Oct 18 - 19, 2021 at Holiday Inn Kensington Forum, London, England, United Kingdom.

Who Should Attend:
Executives, Directors, VPs, Heads, Principals, Managers of:
• Drug-Delivery Developers
• Autoinjectors
• Device Engineering
• Human Factors
• Injectables
• Packaging
• Regulatory Affairs
• Connectivity
• Medical Device Data
• Novel Product Technology
• Smart Device Developers
• Device Safety Solution Providers

or anyone who works with Wearable Devices/ On-Body Injectors within pharmaceuticals, biotech, device developers and solution providers.

Description:
The latest innovations in digital health and on-body drug delivery for the pharmaceutical industry

SMi’s 2nd annual Wearable Injectors and Connected Devices Conference will explore real world case studies of on-body device design and development for large volume delivery while engaging in the latest digital applications for wearable devices with industry case studies from pharma thought leaders. The conference will consider key developments in the wearable injectors field, including the enhanced demand for on-body injectors and digitalised health as the pandemic highlights the need for self-administered at-home care, managing sustainability in the field, and opportunities for development in oncology.

Key regulatory updates including guidance on MDR requirements and the impact of Brexit on data collection will be presented by regulatory experts for a comprehensive outlook of this exciting and ever-growing field, and the importance of considering human factors in order to enhance the user experience will be presented by industry experts.

This two-day agenda offers you peer-to-peer networking with Global Device Development Managers, Senior Connectivity Engineers, Leaders in Device Data Generation, Human Factors Directors and many more.

We look forward to welcoming you to the conference in October.

Benefits of Attending:
• Gain insight into developments in wearable devices in clinical trials and adapting to decentralised trials during the pandemic
• Explore design strategies for connectivity and digital health with sessions from Novartis and Bayer
• Hear key regulatory updates from regulatory and notified bodies including TÜV SÜD
• Discover advances in device design for large volume delivery via on-body injectors
• Explore and benchmark against industry developments through case studies and real-world examples in device development for on-body injectors

Plus, two interactive half-day workshops - Wednesday 20th October 2021

A: Cross company collaboration to develop digital therapeutic solutions using connected devices
Workshop Leader:
Digby Harris, Global Procurement Lead – Digital Therapeutics, AstraZeneca

B: Optimising Patient Engagement and Creating Novel Company Value through Digital Technologies
Workshop Leaders:
Alex Gilbert, Digital Medicine, Huma